Nanoscale Lipophilic Prodrugs of Dexamethasone with Enhanced Pharmacokinetics-Reference-Cited by-同舟云学术

Nanoscale Lipophilic Prodrugs of Dexamethasone with Enhanced Pharmacokinetics

Published:2019-05-22 Issue:7 Volume:16 Page:2999-3010
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Lorscheider Mathilde¹,Tsapis Nicolas¹^ORCID,Simón-Vázquez Rosana²,Guiblin Nicolas³,Ghermani Noureddine¹^ORCID,Reynaud Franceline¹⁴,Canioni Romain¹,Abreu Sonia⁵,Chaminade Pierre⁵,Fattal Elias¹^ORCID

Affiliation:

1. Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Univ. Paris-Saclay, 92290 Châtenay-Malabry, France

2. Immunology, Biomedical Research Center (CINBIO) and Institute of Biomedical Research of Orense, Pontevedra and Vigo (IBI), University of Vigo, Campus Lagoas Marcosende, Pontevedra 36310, Spain

3. École Centrale Paris, Laboratoire Structures, Propriétés et Modélisation des Solides (SPMS), UMR CNRS 8580, CentraleSupélec, Univ. Paris Saclay, 3 Rue Joliot Curie, 91190 Gif-sur-Yvette, France

4. School of Pharmacy, Federal University of Rio de Janeiro, 21944-59 Rio de Janeiro, Brazil

5. Lip(Sys)2 EA7357 Lipides, Systèmes analytiques et biologiques, Univ. Paris-Sud, Univ. Paris-Saclay, 92290 Châtenay-Malabry, France

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b00237

Reference43 articles.

1. The epidemiology of glucocorticoid-associated adverse events

2. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events

3. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system